| Literature DB >> 27879899 |
Carlo Camerlingo1, Flora Zenone2, Giuseppe Perna3, Vito Capozzi3, Nicola Cirillo4, Giovanni Maria Gaeta4, Maria Lepore5.
Abstract
A wavelet multi-component decomposition algorithm has been used for data analysis of micro-Raman spectra of blood serum samples from patients affected by pemphigus vulgaris at different stages. Pemphigus is a chronic, autoimmune, blistering disease of the skin and mucous membranes with a potentially fatal outcome. Spectra were measured by means of a Raman confocal microspectrometer apparatus using the 632.8 nm line of a He-Ne laser source. A discrete wavelet transform decomposition method has been applied to the recorded Raman spectra in order to overcome problems related to low-level signals and the presence of noise and background components due to light scattering and fluorescence. This numerical data treatment can automatically extract quantitative information from the Raman spectra and makes more reliable the data comparison. Even if an exhaustive investigation has not been done in this work, the feasibility of the follow-up monitoring of pemphigus vulgaris pathology has been clearly proved with useful implications for the clinical applications.Entities:
Keywords: blood serum; micro-Raman spectroscopy; wavelet analysis
Year: 2008 PMID: 27879899 PMCID: PMC3924941 DOI: 10.3390/s8063656
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Figure 1.Outline of Raman signal elaboration by wavelet algorithm. The raw data spectra (a and b) are decomposed by Discrete Wavelet Transform (DWT) in the components D1,…,D8, A8 (c and d). Using the Inverted Discrete Wavelet Transform (IDWT) the signal is reconstructed from D5,.., D8 components (e and f).
Figure 2.Typical Raman spectrum of blood serum from patients with active PV (a), under drug therapy (b) and from a recovered patient (c).
Figure 3.Behavior of R2 resulting from linear regression of Raman spectra relative to blood serum from patients in the remission stage of illness (recovered), from patients under drug therapy and from PV active patients in the wavenumber 1000-1800 cm-1. Dots and bar indicate the mean of R2 and the error in its determination.
Figure 4.Typical Raman spectrum from under drug therapy (a) and PV active patients (b). The spectra are compared to the spectrum of recovered patient (thin lines) by means of linear regression analysis. The residual signal between signal in (a), signal in (b) and reference signal (from recovered patient) is reported in (c) and (d) respectively.